Literature DB >> 24827649

Mesenchymal phosphaturic tumour: early detection of recurrence.

Fabiana Allevi1, Dimitri Rabbiosi2, Marco Mandalà3, Giacomo Colletti2.   

Abstract

The case of a recurrent phosphaturic mesenchymal tumour of the maxillary sinus 10 years after the first surgical excision is reported. The neoplasm first presented with paraneoplastic osteomalacia causing a pathological femur fracture. A right maxillary sinus tumour was identified and treated thereafter. The patient had no local symptoms and serum electrolytes returned to normal after surgical removal of the tumour. However, 10 years later, the patient's urine Ca and P levels increased and an octreoscan detected a new tumour in the right maxillary sinus. Early diagnosis prevented the effects of the paraneoplastic activity of the neoplasm. This case emphasises the importance of specific, close follow-up, because the neoplasm rarely produces local signs indicating its position. To our knowledge, this is the first reported case of a late relapse presenting without relevant symptoms (local pain or swelling or pathological fractures). 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24827649      PMCID: PMC4025255          DOI: 10.1136/bcr-2013-202827

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

Review 1.  Oncogenic osteomalacia.

Authors:  M Sundaram; E F McCarthy
Journal:  Skeletal Radiol       Date:  2000-03       Impact factor: 2.199

2.  Octreotide for tumor-induced osteomalacia.

Authors:  Federica Paglia; Simona Dionisi; Salvatore Minisola
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

3.  [Rickets following bone tumor].

Authors:  A PRADER; R ILLIG; E UEHLINGER; G STALDER
Journal:  Helv Paediatr Acta       Date:  1959-12

4.  Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy.

Authors:  Y Rhee; J D Lee; K H Shin; H C Lee; K B Huh; S K Lim
Journal:  Clin Endocrinol (Oxf)       Date:  2001-04       Impact factor: 3.478

5.  Primary giant cell tumor of soft tissues: a study of 22 cases.

Authors:  A M Oliveira; A P Dei Tos; C D Fletcher; A G Nascimento
Journal:  Am J Surg Pathol       Date:  2000-02       Impact factor: 6.394

6.  Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia.

Authors:  A Ogose; T Hotta; I Emura; H Hatano; Y Inoue; H Umezu; N Endo
Journal:  Skeletal Radiol       Date:  2001-02       Impact factor: 2.199

7.  Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia.

Authors:  Yasuhiro Takeuchi; Hisanori Suzuki; Sayoko Ogura; Rie Imai; Yuji Yamazaki; Takeyoshi Yamashita; Yoshinari Miyamoto; Hiroshi Okazaki; Kozo Nakamura; Kazuhiko Nakahara; Seiji Fukumoto; Toshiro Fujita
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

8.  Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets.

Authors:  N Weidner; D Santa Cruz
Journal:  Cancer       Date:  1987-04-15       Impact factor: 6.860

9.  Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.

Authors:  Andrew L Folpe; Julie C Fanburg-Smith; Steven D Billings; Michele Bisceglia; Franco Bertoni; Justin Y Cho; Michael J Econs; Carrie Y Inwards; Suzanne M Jan de Beur; Thomas Mentzel; Elizabeth Montgomery; Michal Michal; Markku Miettinen; Stacey E Mills; John D Reith; John X O'Connell; Andrew E Rosenberg; Brian P Rubin; Donald E Sweet; Tuyethoa N Vinh; Lester E Wold; Brett M Wehrli; Kenneth E White; Richard J Zaino; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2004-01       Impact factor: 6.394

10.  Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue.

Authors:  Naoki Uramoto; Mitsuru Furukawa; Tomokazu Yoshizaki
Journal:  Auris Nasus Larynx       Date:  2008-03-07       Impact factor: 1.863

View more
  3 in total

Review 1.  Phosphaturic Mesenchymal Tumor: 2 New Oral Cases and Review of 53 Cases in the Head and Neck.

Authors:  Hiba Qari; Aya Hamao-Sakamoto; Clay Fuselier; Yi-Shing Lisa Cheng; Harvey Kessler; John Wright
Journal:  Head Neck Pathol       Date:  2015-11-14

2.  CT and MR imaging features in phosphaturic mesenchymal tumor-mixed connective tissue: A case report.

Authors:  Zhenshan Shi; Yiqiong Deng; Xiumei Li; Yueming Li; Dairong Cao; Vikash Sahadeo Coossa
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

3.  Tumor induced osteomalacia in head and neck region: single center experience and systematic review.

Authors:  Ravikumar Shah; Anurag R Lila; Ramteke-Swati Jadhav; Virendra Patil; Abhishek Mahajan; Sushil Sonawane; Puja Thadani; Anil Dcruz; Prathamesh Pai; Munita Bal; Subhada Kane; Nalini Shah; Tushar Bandgar
Journal:  Endocr Connect       Date:  2019-10       Impact factor: 3.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.